Literature DB >> 27555486

The efficacy of interlaminar epidural steroid administration in multilevel intervertebral disc disease with chronic low back pain: a randomized, blinded, prospective study.

Korgün Ökmen1, Burcu Metin Ökmen2.   

Abstract

BACKGROUND CONTEXT: Epidural steroid injection is commonly used in patients with chronic low back pain. Applying a mixture of a local anesthetic (LA) and steroid using the interlaminar (IL), transforaminal, and caudal techniques is a preferred approach.
PURPOSE: The present study aims to investigate the efficacy of interlaminar epidural steroid administration in patients with multilevel lumbar disc pathology (LDP) and to assess the possible correlation of the procedure's success with age and body mass index (BMI). STUDY
DESIGN: A randomized controlled trial was performed. PATIENT SAMPLE: We administered interlaminar epidural steroid to a total of 98 patients with multilevel LDP. OUTCOME MEASURES: The visual analog scale (VAS) and Oswestry Disability Index (ODI) scoring were performed on the study population at pretreatment (PRT), posttreatment, and 1, 3, 6, and 12 PRT months. A possible correlation of BMI and age with the procedure success was evaluated.
METHODS: The LA group (Group L, n=50) received 10 mL 0.25% bupivacaine, whereas the steroid+LA group (Group S, n=48) received 10 mL 0.25% bupivacaine+40 mg methylprednisolone at L4-L5 intervertebral space in prone position under the guidance of C-arm fluoroscopy.
RESULTS: There was no statistical difference in the PRT VAS and ODI scores between the groups (p<.05), whereas the VAS and ODI scores at 1, 3, 6, and 12 posttreatment months were higher in Group L, compared with Group S (p<.05). Age and BMI were not found to be related with the success of the procedure.
CONCLUSIONS: Our study results showed that the VAS and ODI scores were lower in patients with multilevel LDP receiving steroid, following the administration of IL epidural injection. However, further studies are required to establish a robust conclusion on the dispersion of IL epidural injections in the epidural area and the dose of steroid.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidural steroid injection; Interlaminar; Local anesthetic; Low back pain; Multiple level radiculopathy; Steroid

Mesh:

Substances:

Year:  2016        PMID: 27555486     DOI: 10.1016/j.spinee.2016.08.024

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  5 in total

1.  Deep Learning-Based Automatic Segmentation of Lumbosacral Nerves on CT for Spinal Intervention: A Translational Study.

Authors:  G Fan; H Liu; Z Wu; Y Li; C Feng; D Wang; J Luo; W M Wells; S He
Journal:  AJNR Am J Neuroradiol       Date:  2019-05-30       Impact factor: 3.825

Review 2.  Does Epidural Bupivacaine with or Without Steroids Provide Long-Term Relief? A Systematic Review and Meta-analysis.

Authors:  Laxmaiah Manchikanti; Nebojsa Nick Knezevic; Allan Parr; Alan D Kaye; Mahendra Sanapati; Joshua A Hirsch
Journal:  Curr Pain Headache Rep       Date:  2020-04-25

3.  Epidural corticosteroid injections for lumbosacral radicular pain.

Authors:  Crystian B Oliveira; Christopher G Maher; Manuela L Ferreira; Mark J Hancock; Vinicius Cunha Oliveira; Andrew J McLachlan; Bart W Koes; Paulo H Ferreira; Steven P Cohen; Rafael Zambelli Pinto
Journal:  Cochrane Database Syst Rev       Date:  2020-04-09

4.  Dispersal Pattern of Injectate After Cervical Epidural Steroid Injection Evaluated With Magnetic Resonance Imaging.

Authors:  Christina L Goldstein; Troy D Pashuck; Kevin L Ingalls; Laura L Billings; Mohammad T Agha; Mark W Drymalski; Theodore J Choma; Joel T Jeffries; Christopher R James
Journal:  Global Spine J       Date:  2019-03-04

5.  Ultrasound-Guided Transforaminal Injections of Platelet-Rich Plasma Compared with Steroid in Lumbar Disc Herniation: A Prospective, Randomized, Controlled Study.

Authors:  Zhen Xu; Shaoling Wu; Xiao Li; Cuicui Liu; Shengnuo Fan; Chao Ma
Journal:  Neural Plast       Date:  2021-05-27       Impact factor: 3.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.